MGRX (Mangoceuticals) Total Liabilities: $0.98 Mil (As of Mar. 2026)


MGRX Mangoceuticals Inc MGRX
28 GF Score
Price $0.47
GF Value $0.31
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Mangoceuticals Total Liabilities?

Mangoceuticals MGRX +11.90% 28 Total Liabilities is $0.98 Mil as of Mar. 2026. GuruFocus rates MGRX with a GF Score™ of 28/100 and a GF Value™ of $0.31 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Mangoceuticals's Total Liabilities for the quarter that ended in Mar. 2026 was $0.98 Mil.

Mangoceuticals's quarterly Total Liabilities increased from Sep. 2025 ($0.80 Mil) to Dec. 2025 ($0.89 Mil) and increased from Dec. 2025 ($0.89 Mil) to Mar. 2026 ($0.98 Mil).

Mangoceuticals's annual Total Liabilities increased from Dec. 2023 ($0.28 Mil) to Dec. 2024 ($1.43 Mil) but then declined from Dec. 2024 ($1.43 Mil) to Dec. 2025 ($0.89 Mil).

Mangoceuticals Total Liabilities Historical Data

* Premium members only.

The historical data trend for Mangoceuticals's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mangoceuticals Total Liabilities Chart

Mangoceuticals Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
0.04 0.39 0.28 1.43 0.89

Mangoceuticals Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.50 1.60 0.80 0.89 0.98
MGRX
28GF Score
Mangoceuticals Inc MGRX
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mangoceuticals Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Mangoceuticals's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.891+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.89

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=16.09-15.199
=0.89

Mangoceuticals's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.738+(0.237+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.98

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=14.449-13.475
=0.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $0.98 Mil mean?
Mangoceuticals (MGRX) has a Total Liabilities of $0.98 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Mangoceuticals and its competitors.
Is Mangoceuticals' Total Liabilities too high?
Mangoceuticals' current Total Liabilities is $0.98 Mil. Overall, Mangoceuticals has a GF Score™ of 28/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Mangoceuticals' Total Liabilities compare to WLSS and ACON?
Mangoceuticals' Total Liabilities of $0.98 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Healthcare Providers & Services company?
A good Total Liabilities depends on the Healthcare Providers & Services industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Mangoceuticals and its competitors. Mangoceuticals's current Total Liabilities is $0.98 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mangoceuticals stock overvalued right now?
Based on GuruFocus' analysis, Mangoceuticals (MGRX) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.31, compared to a current price of $0.47 — trading 50% above its estimated fair value. The current Total Liabilities is $0.98 Mil. Mangoceuticals' overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Mangoceuticals (MGRX), the current Total Liabilities is $0.98 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mangoceuticals (MGRX) Overvalued in 2026?

Based on GuruFocus' analysis, Mangoceuticals stock appears to be overvalued. The current stock price of $0.47 is trading 50% above its estimated GF Value™ of $0.31. GuruFocus considers Mangoceuticals to be Significantly Overvalued.

Key valuation signals for MGRX:

  • Total Liabilities: $0.98 Mil
  • GF Value™: $0.31 vs. price of $0.47 (50% above fair value)
  • GF Score™: 28/100 with 2 warning signs

No single metric tells the full story. See the MGRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mangoceuticals Business Description

Address 17130 Dallas Parkway, Suite 240, Dallas, TX, USA, 75248
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
28GF Score

Get the complete analysis for MGRX

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.47
Price
$0.31
GF Value